XML 16 R7.htm IDEA: XBRL DOCUMENT v3.22.2
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Statement of Cash Flows [Abstract]    
Net income $ 30,001 $ 38,471
Adjustments to reconcile net income to net cash provided by operating activities:    
Provision (benefit) for credit losses 552 (6,075)
ESOP and stock compensation expense 1,697 1,407
Depreciation 1,857 1,945
Amortization of premiums, and deferred loan costs, net of (accretion) discounts, and deferred loan fees 4,915 621
Amortization of intangible assets 93 101
Amortization of operating lease right-of-use assets 2,331 2,167
Income on bank-owned life insurance (1,687) (1,705)
Net gain on sale of loans 0 (1,401)
Gains on available-for-sale debt securities, net (264) (606)
Losses (gains) on trading securities, net 2,365 (1,171)
Gain on sale of other real estate owned, net (17) 0
Net sales of trading securities 695 719
(Increase) decrease in accrued interest receivable (376) 169
Increase in other assets (1,155) (10,020)
(Decrease) increase in accrued expenses and other liabilities (623) 366
Net cash provided by operating activities 40,384 24,988
Cash flows from investing activities:    
Net increase in loans receivable (300,245) (117,546)
Purchases of loans (7,696) 0
Proceeds from sale of loans held-for-sale 0 151,559
Purchases of FHLB of New York stock (5,423) (220)
Redemptions of FHLB of New York stock 7,817 4,353
Purchases of debt securities available-for-sale (164,988) (213,761)
Purchases of equity securities (2,510) 0
Principal payments and maturities on debt securities available-for-sale 193,873 280,050
Principal payments and maturities on debt securities held-to-maturity 76 788
Proceeds from sale of debt securities available-for-sale 41,464 95,472
Proceeds from sale of equity securities 31 34
Proceeds from bank-owned life insurance 1,526 1,021
Proceeds from sale of other real estate owned 125 0
Purchases and improvements of premises and equipment (1,686) (1,025)
Net cash (used in) provided by investing activities (237,636) 200,725
Cash flows from financing activities:    
Net increase in deposits 248,668 31,718
Dividends paid (12,231) (11,839)
Exercise of stock options 231 1,815
Purchase of treasury stock (10,979) (24,833)
Increase in advance payments by borrowers for taxes and insurance 4,549 4,526
Proceeds from issuance of subordinated debt, net of issuance costs 60,917 0
Proceeds from securities sold under agreements to repurchase and other borrowings 261 265
Repayments related to securities sold under agreements to repurchase and other borrowings (75,000) (121,725)
Net cash provided by (used in) financing activities 216,416 (120,073)
Net increase in cash and cash equivalents 19,164 105,640
Cash and cash equivalents at beginning of period 91,068 87,544
Cash and cash equivalents at end of period 110,232 193,184
Cash paid during the period for:    
Interest 6,807 9,833
Income taxes 11,205 19,100
Non-cash transactions:    
Loan charge-offs, net 494 2,392
Right-of-use assets obtained in exchange for new lease liabilities 4,983 0
Transfer of loans held-for-investment to loans held-for-sale at fair value 2,346 131,883
Transfer of loans held-for-sale at fair value to loans held-for-investment 0 1,612
Transfer of loans held-for-investment to other real estate owned $ 0 $ 100